Cargando…
Dexamethasone-Induced Sarcopenia and Physical Frailty in Children With Acute Lymphoblastic Leukemia: Protocol for a Prospective Cohort Study
BACKGROUND: During treatment for pediatric acute lymphoblastic leukemia (ALL), children receive high doses of dexamethasone for its apoptotic effect on leukemia cells; however, muscle atrophy is a well-known serious side effect. Muscle atrophy (loss of muscle mass) accompanied by a decreased muscle...
Autores principales: | Verwaaijen, Emma Jacobine, van Hulst, Annelienke, Fiocco, Marta, Hartman, Annelies, Grootenhuis, Martha, Pluijm, Saskia, Pieters, Rob, van den Akker, Erica, van den Heuvel-Eibrink, Marry M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039819/ https://www.ncbi.nlm.nih.gov/pubmed/35403603 http://dx.doi.org/10.2196/33517 |
Ejemplares similares
-
The utility of a portable muscle ultrasound in the assessment of muscle alterations in children with acute lymphoblastic leukaemia
por: Verwaaijen, Emma J., et al.
Publicado: (2023) -
Unraveling Dexamethasone-Induced Neurobehavioral and Sleep Problems in Children With ALL: Which Determinants Are Important?
por: van Hulst, Annelienke M., et al.
Publicado: (2023) -
Study protocol: DexaDays-2, hydrocortisone for treatment of dexamethasone-induced neurobehavioral side effects in pediatric leukemia patients: a double-blind placebo controlled randomized intervention study with cross-over design
por: van Hulst, A. M., et al.
Publicado: (2021) -
Novel Adaption of the SARC-F Score to Classify Pediatric Hemato-Oncology Patients with Functional Sarcopenia
por: Verwaaijen, Emma J., et al.
Publicado: (2023) -
Risk factors for steroid‐induced adverse psychological reactions and sleep problems in pediatric acute lymphoblastic leukemia: A systematic review
por: van Hulst, Annelienke M., et al.
Publicado: (2021)